Clinical trial
Reveal LINQ™ In-Office 2 (RIO 2) Study United States
NCT02395536 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reveal LINQ™ In-Office 2 (RIO 2) Study United States
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 30, 2015
- Completion date
- May 31, 2016
- Enrollment
- 525 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia